EBD Group is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Key Sessions

Simone Fishburn

The innovation drivers that work

BioCentury Innovations

Evonne Sepsis

A day in the life of experienced dealmakers

ESC Advisors

Nov 07
Show Filter
06:30 - 07:15 45 mins
Main agenda
Rise and Run
more

Pack your running shoes! Explore the city of Berlin while getting your morning workout in. The pace will be comfortable enough to chat and runners of all levels are welcome. Bring hat and gloves for a cold morning, but we will cancel for very inclement weather.

Duration: approximately 45 minutes

Meeting point: Intercontinental Hotel, Entrance

Budapester Str. 2, 10787 Berlin

07:45 - 18:00 615 mins
Main agenda
Registration open
more

Entrance Level, Entrance Lobby

07:45 - 10:30 165 mins
Main agenda
Continental Breakfast
more

Level 2, Hall B

07:45 - 18:00 615 mins
Main agenda
Exhibition Open
more

Level 2, Hall B

08:00 - 18:30 630 mins
Main agenda
One-to-one Meetings
more

Level 1, Hall A

09:00 - 10:00 60 mins
Main agenda
Glycobiotechnology in diagnostics and therapy
  • Moderator Kai Bindseil - Head of Division, Life Sciences | Healthcare Industries, Berlin Partner
  • Panelist Tom Monroe - CEO, Vaxxilon
  • Panelist Peter Seeberger - Director, Max Planck Institute of Colloids and Interfaces
  • Panelist Rudolf Tauber - Director, Institute of Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité – Universitätsmedizin Berlin
more

Level 3, Room M2

Glycans, the predominant biopolymers, play essential roles in health and disease including bacterial as well as viral infections, cancer and immunity.New technologies such as automated glycan assembly and glycan sequencing are enabling a host of biomedical applications of glycans in diagnostics, therapy and preventive medicine. Glyco-engineered biopharmaceuticals and novel diagnostic tools contribute to important advances in the treatment of various diseases.Carbohydrate conjugate vaccines are a market of over EUR 10 billion per year and therapeutic glycoproteins generate over USD 35 billion in annual sales. Fueled by technological advances, the Glycobiotech sector is growing rapidly.The Glycobiology session will present recent developments in the application of glycans as therapeutics and vaccines and as biomarkers for the diagnostics of diseases. Vaxxilon will present a best practice example for the advancement of these scientific discoveries onto the path of development and commercialization of novel vaccines.

09:00 - 10:30 90 mins
Main agenda
EU funding for health research SMEs: The European Innovation Council and beyond
  • Moderator Cornelius Schmaltz - Head of Unit, Directorate Health, European Commission
  • Panelist Stefan Beyer - CEO and Managing Director, Vibalogics
  • Panelist Shiva Dustdar - Head of Division, Innovation Finance Advisory, European Investment Bank
  • Panelist Pierre Meulien - Executive Director, Innovative Medicine Initiative
  • Panelist Bernd Reichert - Head of Unit, Horizon 2020 SME, European Commission Executive Agency for SMEs
more

Level 3, Room M1

How does an innovative and ambitious Small or Medium-sized Enterprise (SME) succeed in accessing European Union (EU) funds to develop new healthcare solutions? This session provides concrete examples of successful SME participation in EU–funded projects and informative insights and advice for applicants from EU policymakers. Due to increasing difficulties in obtaining venture capital funds for life sciences, public support for SMEs in health research is becoming vital. The EU helps to improve the conditions for the emergence and rapid scale-up of highly innovative enterprises by launching the European Innovation Council (EIC) pilot. The EIC supports top-class innovators with the ambition to scale up at the European and global levels by providing funding, mentoring and networking opportunities. The objective is to strengthen breakthrough innovations and boost the number of high-growth companies. The session will provide an overview of the EIC opportunities and will also introduce other Horizon 2020 funding schemes relevant for SMEs, such as calls for collaborative proposals, including the Innovative Medicines Initiative, and InnovFin—the EU Finance for Innovators, co-developed with the European Investment Bank (EIB). For a dynamic and interactive discussion, we will bring together representatives from the European Commission, the Innovative Medicines Initiative, the EIB and an EU–funded SME.

10:45 - 11:45 60 mins
Main agenda
The innovation drivers that work
  • Moderator Simone Fishburn - Editor, BioCentury Innovations
  • Panelist Julia Belaya - Director, Corporate Partnerships, Plug and Play Tech Center
  • Panelist Hun-Che Cho - Managing Director, Korea Drug Research Association (KDRA)
  • Panelist Michal Preminger - Executive Director, Harvard University Office of Technology Development, Harvard Medical School
  • Panelist Jared Sebhatu - Program Director Germany, German Accelerator Life Sciences
more

Level 3, Room M1

The recipe for successful innovation is not always the same. Culture, situational circumstances, environment, and support can all be balanced in different ways to create thriving companies. Join this session to hear about the drivers of innovation from successful start up clusters from around the world.

09:00 - 10:30 90 mins
Main agenda
3P BIO FORUM IV EDITION - Process Validation: Integrating strategies to win the marketplace race
  • Moderator Elena Erroba - Director, Business Development, 3P Biopharmaceuticals
  • Panelist Geert Lissens - Field Marketing Manager, Filtration Technologies, Sartorius Stedim
  • Panelist Toomas Moks, Consultant
  • Panelist Daniel Rivero - Plant Director, 3P Biopharmaceuticals
  • Panelist Victor Sánchez - President and CEO, Pharma-Bio Serv, Inc.
more

Level 3, Room M4

3P BIO FORUM IV EDITION

Process Validation: Integrating strategies to win the marketplace race

Biopharmaceutical development is becoming a space race. Companies are asked for faster assurance that the process has been developed in a robust manner to obtain a product in conformance with regulatory standards. The application of process validation is global and needs to be extended not only to the manufacturer but also to suppliers that have to establish and integrate the same guidelines as the biotech company to certify that products are consistently meeting high quality and safety standards. Industry leaders will cover the main dilemmas and challenges faced by the biotech industry in the biologics process validation with real successful case studies.This high-level panel is composed of international leaders who combine all parts involved in process validation and biologics manufacturing.

10:45 - 12:15 90 mins
Main agenda
Health Technology Assessment in Europe
  • Moderator Bertram Häussler - Chairman, IGES Institute, Berlin
  • Panelist Hannah Brühl - Scientific Advisor, Pharmaceuticals Department, Federal Joint Committee, Berlin, Germany
  • Panelist Marlene Gyldmark - Head, Health Technology Assessment Group (MORSE), Global Pricing and Market Access, Pharmaceutical Division, F. Hoffmann-La Roche
  • Panelist Dierk Neugebauer - Director Market Access Germany, Bristol-Myers Squibb
  • Panelist Constantinos Ziogas - Head of SME Office, European Medicines Agency
more

Level 3, Room M4

This panel provides an overview of the reimbursement systems in Europe with a particular focus on Germany. It explains which aspects are crucial drivers for success while dealing with the European HTA agencies. It will explain in more detail the various aspects of the reimbursement system on the example of Germany. The different challenges in outpatient and inpatient care as well as the situation for orphan and oncology drugs will be discussed. Representatives from the pharmaceutical industry will provide hands-on information about the challenges of some products recently launched in Europe.

09:00 - 11:45 165 mins
Main agenda
Company Presentations
more

Level 3, Rooms M2, M3, M6

Early stage projects, innovative startups, established biotech or midsize pharma companies present their innovative assets or ideas directly in front of real decision makers. Learn more

10:05 - 10:25 20 mins
Main agenda
Break and Breathe
more

Level 3, Room M8

Enhance your conference experience by using simple breathing techniques, movement and light stretches in order to charge your body and mind for better decision making and more energy throughout the day.

Open to all. No prerequisites required. Standing and seated positions only.


11:05 - 11:25 20 mins
Main agenda
Break and Breathe
more

Level 3, Room M8

Enhance your conference experience by using simple breathing techniques, movement and light stretches in order to charge your body and mind for better decision making and more energy throughout the day. Open to all. No prerequisites required. Standing and seated positions only.

12:00 - 13:00 60 mins
Main agenda
A day in the life of experienced dealmakers
  • Moderator Evonne Sepsis - Founder and Managing Director, ESC Advisors
  • Moderator Anton Gueth - Managing Director, EVOLUTION Life Science Partners
  • Panelist Johnston Erwin - VP, Corporate Business Development, Eli Lilly and Company
  • Panelist Nicholas Franco - Executive VP and CBO, Actelion
  • Panelist Berthold Hinzen - Head of Business Development and Licensing, General Medicine, Pharmaceuticals Division,, Bayer Pharma
  • Panelist Amy Schulman - CEO, Lyndra Inc., Polaris Partners
more

Level 3, Room M1

12:00 - 14:00 120 mins
Main agenda
Luncheon
more

Level 2, Hall B; Hall 2 (access via Hall B)

13:00 - 13:30 30 mins
Main agenda
Nanomedicine Award Ceremony
more

Level 3, Room M4

Nanomedicine Award Ceremony 

The third edition of the Nanomedicine Award aims to honor and increase visibility of the best international nanomedicine innovations. 

Candidates should develop a Nanomedicine solution that could bring large benefits to patients, changing the way diseases are treated or diagnosed or providing new tools for physicians. 

Two excellent projects in Nanomedicine have been awarded, every two years, since 2013. For 2017, the Nanomedicine Award has two categories:        

-  Most Promising Nanomedicine Project

-  Best Nanomedicine Product/Deal

For more information, or to apply, please visit http://nanomedicine-award.com/. 

During the Nanomedicine Award Ceremony, winners will be announced by the Chairman of the European Technology Platform on Nanomedicine (ETPN).


13:30 - 14:30 60 mins
Main agenda
Disruption in Healthcare: What’s coming next?
  • Moderator Mike Ward - Global Director of Content, Informa Pharma Insights
  • Panelist Geraldine Hamilton - President and CSO, Emulate
  • Panelist Laurent Levy - CEO, Nanobiotix
  • Panelist Chris Van Hoof - Director Wearable Healthcare, IMEC
  • Panelist Eric Vibert - Liver Surgeon, Hospital Paul Brousse
more

Disruptive Talks are innovative healthcare events with a disruptive theme and format. They engage and make the audience think about how disruptive innovations in healthcare could impact their own business.The objective? Challenge the future of healthcare by showing that disruption has already started in the healthcare sector technologically and business speaking.

16:45 - 17:45 60 mins
Main agenda
CMC Session
more

Level 3, Room M4

Join us for our talk session at BioEurope!  

What are the challenges of fast-tracking your product to IND while meeting market demands? 

  • Introduction to CMC/Biomeva/AGC 
    • Speaker:  Andy Lewin, VP, Business Development, CMC Biologics
  • What are CDMOs doing to meet the growing market demands?  What are the latest outsourcing trends & capacity?  (20 min)
    • Speaker: Roland Hecht, Sr. Director, Business Development, Biomeva
  • Implementation of various high through-put technologies for accelerated process development of biopharmaceuticals (30 min)
    • Torben P. Frandsen, SVP Process Development and Technology Coordination, CMC Biologics, Denmark 


Visit us at our booth 107 & 108, for a celebratory reception starting at 5:45pm!!!

14:00 - 17:30 210 mins
Main agenda
Company Presentations
more

Level 3, Rooms M2, M3, M6

Early stage projects, innovative startups, established biotech or midsize pharma companies present their innovative assets or ideas directly in front of real decision makers. Learn more

15:00 - 17:30 150 mins
Main agenda
Startup Slam: Berlin
  • Moderator Emma Kohring - Communications Leader, Johnson & Johnson Innovation
  • Moderator Marek Tyl - Chief Executive, The Innovation Forum
  • Judge Ann Beliën - Founder and CEO, Rejuvenate Biomed
  • Judge Craig Garner - Prof Charité, Founder, SPARK-Berlin
  • Judge Regina Hodits - Partner, Wellington Partners
  • Judge Joris De Maeyer - Venture Coach, Bioqube Ventures
  • Judge Pavithra Sundaresan - Senior Director, New Ventures and Transactions, Immunology, Johnson & Johnson Innovation
more

Level 3, Room M1

Startup Slam is a pitching competition offering emerging entrepreneurs a chance to pitch their company. Selected companies will present their innovative technologies to a panel of judges comprising business development executives, venture capitalists and industry experts.

Find out more  »
16:05 - 16:25 20 mins
Main agenda
Break and Breathe
more

Level 3, Room M8

Enhance your conference experience by using simple breathing techniques, movement and light stretches in order to charge your body and mind for better decision making and more energy throughout the day. 

Open to all. No prerequisites required.Standing and seated positions only.


17:05 - 17:25 20 mins
Main agenda
Break and Breathe
more

Level 3, Room M8

Enhance your conference experience by using simple breathing techniques, movement and light stretches in order to charge your body and mind for better decision making and more energy throughout the day. Open to all. No prerequisites required. Standing and seated positions only.

17:45 - 18:45 60 mins
Main agenda
Exhibit Hall Hospitality Receptions
more

Exhibition: Level 2, Hall B

Berlin Partner for Business and Technology / HealthCapital – Booth #59

Biopartner UK – Booth # 82

CMC Biologics – Booth #107 + 108

Health~Holland – Booth #73

Life Science Nord – Booth #88

LISAvienna – Booth #62

17:45 - 18:45 60 mins
Main agenda
Speed Matters! Race against your peers...
more
Join us at the Carrera® race track lounge and be the winner.

Sponsored by: JSR Life Sciences

Location: Exhibition – Hall B

19:00 - 23:00 240 mins
Main agenda
Evening Networking Reception with Buffet-style Dinner
more

Venue:

STATION Berlin | Luckenwalder Str. 4–6 | 10963 Berlin

STATION Berlin, formerly known as Postbahnhof, was opened in 1875 as a train station for the handling of mail and parcels to and from Dresden, Prague and Vienna. The station, a crucial lifeline connecting West Berlin with West Germany during the Cold War, finally closed in 1997. Its massive gates, restored roof and countless other details bear witness to its historical significance and eventful past. To this day, STATION Berlin is a hub—a figurative hub for innovative ideas, ingenious products and incomparable events.

18:45–19:15 Shuttle buses depart from the conference center to the evening event.

21:30–22:30 Shuttle buses depart from the evening event to all conference hotels.